Author:
Rank Matthew A.,Liesinger Juliette T.,Branda Megan E.,Gionfriddo Michael R.,Schatz Michael,Zeiger Robert S.,Shah Nilay D.
Funder
Genentech
Agency for Healthcare Research and Quality
National Center for Advancing Translational Sciences
National Institutes of Health
GlaxoSmithKline
Novartis
Mayo Clinic
Subject
Immunology,Immunology and Allergy
Reference18 articles.
1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2014 update. Available at: http://www.ginasthma.org/local/uploads/files/GINA_Report_2014_Aug12.pdf. Accessed September 19, 2014.
2. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Available at: http://www.nhlbi.nih.gov/about/naepp/. Accessed September 19, 2014.
3. The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: a systematic review and meta-analysis of randomized controlled trials;Rank;J Allergy Clin Immunol,2013
4. The risk of asthma exacerbation after reducing inhaled corticosteroids: a systematic review and meta-analysis of randomized controlled trials;Hagan;Allergy,2014
5. Long-acting β2-agonist step-off in patients with controlled asthma;Brozek;Arch Intern Med,2012
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献